Skip to main content

ORIGINAL RESEARCH article

Front. Pharmacol.
Sec. Ethnopharmacology
Volume 15 - 2024 | doi: 10.3389/fphar.2024.1445597
This article is part of the Research Topic Traditional Clinical Symptoms and Signs: How Can They Be Used to Investigate Medications in the Context of Pharmacology? View all 10 articles

Zhachong Shisanwei Pill drug-containing serum protects H2O2-Induced PC12 Cells Injury by Suppressing Apoptosis, Oxidative Stress via regulating the MAPK signaling pathway

Provisionally accepted
汉琼 胡 汉琼 胡 1*Yifan Sun Yifan Sun 1Zhen Yang Zhen Yang 1Mingyang Cai Mingyang Cai 2Xiaoxuan Li Xiaoxuan Li 1Xianju Huang Xianju Huang 3Hurile bagen Hurile bagen 4Wulan qiqige Wulan qiqige 4Wuyunsiri guleng Wuyunsiri guleng 3,5Liqun Ma Liqun Ma 3Haiying Tong Haiying Tong 1*
  • 1 Beijing University of Chinese Medicine, Beijing, China
  • 2 First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan Province, China
  • 3 South-Central University for Nationalities, Wuhan, Hubei Province, China
  • 4 Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region, China
  • 5 Inner Mongolia International Hospital, Hohhot, Inner Mongolia Autonomous Region, China

The final, formatted version of the article will be published soon.

    Introduction: Zhachong Shisanwei Pill (ZSP) is a classical Mongolian formula that combines 13 types of Chinese medicinal materials and has been used for treating ischemic stroke (IS) for centuries. However, the underlying molecular mechanisms have yet to be fully elucidated. The aim of this study is to explore potential mechanism of ZSP on nerve cells in cerebral ischemic injury. Methods: To simulate the pathological process of oxidative stress following IS, an injury model using PC12 cells was induced with hydrogen peroxide (H2O2). Afterward, PC12 cells were treated with ZSP medicated serum at low, medium, and high doses. Various assays were conducted to assess cell viability and oxidative stress indicators, including lactate dehydrogenase (LDH), malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), reactive oxygen species (ROS), and mitochondrial membrane potential (MMP). Cell apoptosis was evaluated through morphological assessment and flow cytometry. Additionally, the expression levels of apoptosis-related proteins (Bcl-2, Bax, Caspase-9, Caspase-3, PARP) and signaling pathway proteins (JNK, phosphorylated JNK, ERK, phosphorylated ERK, p38, and phosphorylated p38) were measured using automated western blotting. Results: Our findings indicate that ZSP medicated serum preconditioning improves the condition of PC12 cells injured by H2O2. Specifically, it increased cell survival rates and reduced LDH release. Additionally, ZSP treatment decreased ROS levels and MDA content, while enhancing the activity of SOD and CAT in the injured PC12 cells. ZSP also reversed the depolarization of mitochondrial membrane potential and protected cells from apoptosis by modulating the expression of apoptosis-related proteins, including Bcl-2, Bax, Caspase-9, Caspase-3, and PARP. Furthermore, the overactivation of the MAPK signaling pathway due to H2O2-induced injury was inhibited, as evidenced by the downregulation of phosphorylated JNK, ERK, and p38 levels. Discussion: Mongolian medicine ZSP demonstrates protective effects against H2O2-induced oxidative stress and apoptosis in PC12 cells. The underlying mechanism may involve the inhibition of the MAPK signaling pathway, enhancement of antioxidant enzyme activity, reduction of intracellular peroxidation levels, and suppression of intrinsic apoptosis pathways.

    Keywords: Zhachong shisanwei pill (ZSP), Ischemic stroke (IS), Oxidative Stress, PC12 Cells, MAPK pathway

    Received: 07 Jun 2024; Accepted: 23 Sep 2024.

    Copyright: © 2024 胡, Sun, Yang, Cai, Li, Huang, bagen, qiqige, guleng, Ma and Tong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    汉琼 胡, Beijing University of Chinese Medicine, Beijing, China
    Haiying Tong, Beijing University of Chinese Medicine, Beijing, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.